NASDAQ: ADPT · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Adaptive Biotechnologies Corporation

How Adaptive Biotechnologies Corporation compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$4.5B

Price

$28.17

P/E

-70.2

EPS (TTM)

$-0.40

1-year return

67.7%

Dividend yield

0.0%

52-week range

$16.32–$28.90

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources